- Home
- SANM vs ACLX Comparison
SANM vs ACLX Comparison
Compare SANM & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SANM | ACLX |
|---|---|---|
| Founded | 1980 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.7B |
| IPO Year | 1994 | 2022 |
Fundamental Metrics
Financial Performance| Metric | SANM | ACLX |
|---|---|---|
| Price | $154.25 | $114.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 15 |
| Target Price | ★ $155.00 | $115.85 |
| AVG Volume (30 Days) | 511.0K | ★ 1.0M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.07 | N/A |
| EPS | ★ 0.89 | N/A |
| Revenue | ★ $7,890,475,000.00 | $22,286,000.00 |
| Revenue This Year | $75.52 | $411.22 |
| Revenue Next Year | $13.59 | $138.37 |
| P/E Ratio | $171.38 | ★ N/A |
| Revenue Growth | ★ 16.78 | N/A |
| 52 Week Low | $71.84 | $47.86 |
| 52 Week High | $185.29 | $114.94 |
Technical Indicators
Market Signals| Indicator | SANM | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 66.98 | 80.84 |
| Support Level | $140.94 | $66.06 |
| Resistance Level | $163.34 | N/A |
| Average True Range (ATR) | 5.79 | 0.16 |
| MACD | 3.49 | -1.09 |
| Stochastic Oscillator | 93.66 | 89.36 |
Price Performance
Historical ComparisonAbout SANM Sanmina Corporation
Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense, and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue mainly in the United States, China, and Mexico, but has a presence around the world.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.